HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

All News

Bristol Myers to Fund Inflammatory Bowel Disease Treg Therapies

GentiBio will use their proprietary regulatory T cell platform to develop the engineered therapies against multiple targets.

Shannon L. Maude, MD, PhD, on Favorable Safety of Tisagenlecleucel in Pediatric B-ALL

The oncologist from Children's Hospital of Philadelphia discussed long-term safety data with tisagenlecleucel in pediatric patients with acute lymphoblastic leukemia.

CGTLive’s Weekly Rewind – August 12, 2022

Review top news and interview highlights from the week ending August 12, 2022.